ライフサイエンスコーパス: ventriculography

1 aired diastolic function, as assessed by PET ventriculography.

2 namic monitoring and first-pass radionuclide ventriculography.

3 razoxane, using blinded serial radionucleide ventriculography.

4 CF) histologically, and ejection fraction by ventriculography.

5 jection fraction as measured by radionuclide ventriculography.

6 ging study or coronary angiography with left ventriculography.

7 icrog/kg/min, using equilibrium radionuclide ventriculography.

8 SPECT (gated SPECT, n = 88) with first-pass ventriculography.

9 secutive patients, referred for radionuclide ventriculography.

10 fusion therapy, 1300 patients underwent left ventriculography.

11 mpedance, and 121 +/- 35 mL, as estimated by ventriculography.

12 63 +/- 8% by bioimpedance and 53 +/- 15% by ventriculography.

13 ntricular volumetric data were determined by ventriculography.

14 ser in value to those obtained with contrast ventriculography.

15 p < 0.001) than those obtained with contrast ventriculography.

16 tients had their EF measured by radionuclide ventriculography 5 years after study entry.

17 g regional wall motion abnormalities on left ventriculography (52.6% vs. 19.2% [P = 0.019]).

18 There is large variation in the use of left ventriculography across VA facilities that is not explai

19 chocardiography in 10 of 10, and normal left ventriculography and coronary angiography in 6 of 7.

20 Left ventriculography and coronary angiography were performed

21 Radionuclide ventriculography and electrocardiographic (ECG) monitori

22 Serial radionuclide ventriculography and endomyocardial biopsies were perfor

23 cluded noninvasive testing with radionuclide ventriculography and exercise thallium scintigraphy, fol

24 ejection fraction (measured by radionuclide ventriculography) and peak oxygen consumption and exerci

25 ng, treadmill exercise testing, radionuclide ventriculography, and coronary angiography.

26 All underwent angiography, ventriculography, and pressure measurements within 48 ho

27 actions were assessed by echocardiography or ventriculography, and spatial QT dispersion was determin

28 llium scintigraphy and exercise radionuclide ventriculography are suboptimal screening tests for coro

29 t and hospital predictors of the use of left ventriculography as well as the variation in use across

30 Survival Trial measured LVEF by radionuclide ventriculography at baseline and at 3 and 12 months afte

31 ic function, using quantitative radionuclide ventriculography at baseline, repeated after 1 year of t

32 sided heart catheterization and radionuclide ventriculography at rest and during exercise.

33 ional function were assessed by radionuclide ventriculography at rest and during two 5-minute standar

34 s, gas exchange, and first-pass radionuclide ventriculography at rest and with cycle ergometry before

35 components (e.g., hemodynamic measurements, ventriculography) at the discretion of the operator.

36 ide ventriculography (RVG) and contrast left ventriculography (Cath-EFa) to predict cardiovascular ev

37 Use of left ventriculography decreased over time (64% in 2000 to 50%

38 he Stroop test were measured by radionuclide ventriculography, ECG, and blood pressure and catecholam

39 EF estimated by contrast ventriculography, echocardiography, or radionuclide stud

40 At 5- to 7-day follow-up ventriculography, ejection fraction was reduced, and end

41 ents of myocardial perfusion and metabolism, ventriculography, endothelial vascular function and coro

42 Echocardiography or contrast ventriculography evaluated regional wall motion.

43 The LVEF was re-assessed by radionuclide ventriculography gated-blood pool (MUGA) scan at six and

44 ions were measured, and cardiac radionuclide ventriculography, Holter monitoring, and polysomnography

45 This was followed by the development of ventriculography in 1918, pneumoencephalography in 1919,

46 ht to determine variation in the use of left ventriculography in the Veterans Affairs (VA) Health Car

47 was change in LVEF, measured by radionuclide ventriculography, in hibernators versus non-hibernators,

48 Contrast left ventriculography is a method of measuring left ventricul

49 mation of EF by (82)Rb PET, compared with CT ventriculography, is present, which is a result of under

50 e compared with those determined by contrast ventriculography (n = 54, including 45 biplane and 9 sin

51 al function was determined with radionuclide ventriculography (n = 8), and myocardial necrosis was lo

52 taneous high-resolution contrast-enhanced CT ventriculography, obtained as a byproduct a CT coronary

53 rest and during exercise using radionuclide ventriculography, peak Vo(2), symptoms, quality of life,

54 irty-five patients had exercise radionuclide ventriculography performed.

55 llium scintigraphy and exercise radionuclide ventriculography performed; when either test was abnorma

56 otential advantages over planar radionuclide ventriculography (PRNV), including the possibility of gr

57 s radionuclide angiography and both contrast ventriculography (r = 0.83) and SPECT (r = 0.87).

58 measure ejection fraction (EF)-radionuclide ventriculography (RVG) and contrast left ventriculograph

59 First-pass (FP) radionuclide ventriculography (RVG) and gated sestamibi perfusion SPE

60 Left ventriculography showed severe anterior hypokinesis, and

61 In addition, left ventriculography showed that obstruction was caused by a

62 rt upright cycle ergometry with radionuclide ventriculography to determine rest and exercise cardiova

63 eter to obtain LV pressures and radionuclide ventriculography to obtain LV volumes during multiple lo

64 went cardiac catheterization, including left ventriculography, up to 16 days after MI.

65 olic volume as estimated by bioimpedance and ventriculography was -139 to 113 mL.

66 ction fraction estimated by bioimpedance and ventriculography was -35% to 37%.

67 ar ejection fraction defined by radionuclide ventriculography was 24 +/- 2% (mean +/- SE).

68 Radionuclide ventriculography was performed at baseline and at peak m

69 Left ventriculography was performed during the index procedur

70 tion procedures among 336 853 patients, left ventriculography was performed on 263 695 (58%) patients

71 -infarct zone contractile function at 90-min ventriculography was similar in both groups.

72 prior 30 days and no intervening event, left ventriculography was still performed in 50% of cases.

73 Contrast left ventriculography was used to measure left ventricular ej

74 Contrast left ventriculography was used to measure left ventricular fu

75 namic monitoring and first-pass radionuclide ventriculography were performed at rest and during exerc

76 and the volumetric data estimated from left ventriculography, were wide, making the degree of agreem

77 lanar thallium scintigraphy and radionuclide ventriculography), where the use of coronary angiography

78 scintigraphy and also exercise radionuclide ventriculography with coronary angiography in diabetic p